162 related articles for article (PubMed ID: 15315477)
1. Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.
Cancio R; Spadari S; Maga G
Biochem J; 2004 Nov; 383(Pt. 3):475-82. PubMed ID: 15315477
[TBL] [Abstract][Full Text] [Related]
2. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
[TBL] [Abstract][Full Text] [Related]
3. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
[TBL] [Abstract][Full Text] [Related]
4. p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
Bakhanashvili M
Oncogene; 2001 Nov; 20(52):7635-44. PubMed ID: 11753641
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effects of truncating alpha-helix E' of p66 human immunodeficiency virus type 1 reverse transcriptase on template-primer binding and fidelity of DNA synthesis.
Menéndez-Arias L
Biochemistry; 1998 Nov; 37(47):16636-44. PubMed ID: 9843431
[TBL] [Abstract][Full Text] [Related]
6. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
Ji X; Klarmann GJ; Preston BD
Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
[TBL] [Abstract][Full Text] [Related]
7. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis.
Weiss KK; Chen R; Skasko M; Reynolds HM; Lee K; Bambara RA; Mansky LM; Kim B
Biochemistry; 2004 Apr; 43(15):4490-500. PubMed ID: 15078095
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes.
Gorshkova II; Rausch JW; Le Grice SF; Crouch RJ
Anal Biochem; 2001 Apr; 291(2):198-206. PubMed ID: 11401293
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease.
Hutoran M; Britan E; Baraz L; Blumenzweig I; Steinitz M; Kotler M
Virology; 2004 Dec; 330(1):261-70. PubMed ID: 15527851
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic insights into the role of Val75 of HIV-1 reverse transcriptase in misinsertion and mispair extension fidelity of DNA synthesis.
Matamoros T; Kim B; Menéndez-Arias L
J Mol Biol; 2008 Feb; 375(5):1234-48. PubMed ID: 18155043
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
12. Chimeric thermostable DNA polymerases with reverse transcriptase and attenuated 3'-5' exonuclease activity.
Schönbrunner NJ; Fiss EH; Budker O; Stoffel S; Sigua CL; Gelfand DH; Myers TW
Biochemistry; 2006 Oct; 45(42):12786-95. PubMed ID: 17042497
[TBL] [Abstract][Full Text] [Related]
13. Interactions between human immunodeficiency virus type 1 reverse transcriptase, tRNA primer, and nucleocapsid protein during reverse transcription.
Hsu M; Wainberg MA
J Hum Virol; 2000; 3(1):16-26. PubMed ID: 10774803
[TBL] [Abstract][Full Text] [Related]
14. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 nucleocapsid traps reverse transcriptase on nucleic acid substrates.
Grohmann D; Godet J; Mély Y; Darlix JL; Restle T
Biochemistry; 2008 Nov; 47(46):12230-40. PubMed ID: 18947237
[TBL] [Abstract][Full Text] [Related]
16. The role of phenylalanine-119 of the reverse transcriptase of mouse mammary tumour virus in DNA synthesis, ribose selection and drug resistance.
Entin-Meer M; Sevilya Z; Hizi A
Biochem J; 2002 Oct; 367(Pt 2):381-91. PubMed ID: 12097136
[TBL] [Abstract][Full Text] [Related]
17. A reiterative mode of DNA synthesis adopted by HIV-1 reverse transcriptase after a misincorporation.
Ricchetti M; Buc H
Biochemistry; 1996 Nov; 35(47):14970-83. PubMed ID: 8942663
[TBL] [Abstract][Full Text] [Related]
18. Stepping statistics of single HIV-1 reverse transcriptase molecules during DNA polymerization.
Ortiz TP; Marshall JA; Meyer LA; Davis RW; Macosko JC; Hatch J; Keller DJ; Brozik JA
J Phys Chem B; 2005 Aug; 109(33):16127-31. PubMed ID: 16853049
[TBL] [Abstract][Full Text] [Related]
19. RNA secondary structure switching during DNA synthesis catalyzed by HIV-1 reverse transcriptase.
Suo Z; Johnson KA
Biochemistry; 1997 Dec; 36(48):14778-85. PubMed ID: 9398198
[TBL] [Abstract][Full Text] [Related]
20. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
Xu W; Morrow CD
Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
